Anti-Human CD5 (Clone UCHT-2) – Purified (PhenoCyler-Fusion (CODEX)® Ready)
Anti-Human CD5 (Clone UCHT-2) – Purified (PhenoCyler-Fusion (CODEX)® Ready)
Product No.: C505
- -
- -
Clone UCHT-2 Target CD5 Formats AvailableView All Product Type Monoclonal Antibody Alternate Names Leu-1, Ly-1, T1, Tp67 Isotype IgG1 Applications IHC FF , PhenoCycler® |
- -
- -
CODEX® DetailsValidation Notes Clone UCHT-2 has been validated for use on CODEX® using human tonsil fresh frozen (FF) tissue. Tissue Screened Tonsil Tissue Preparation FF (Fresh Frozen) Antibody and Reporter DetailsReactivity Species Human Host Species Mouse Concentration 0.5 mg/ml Formulation This purified antibody is formulated in 0.01 M phosphate buffered saline (150 mM NaCl) PBS pH 7.4. Storage and Handling This antibody is stable for at least one week when stored at 2-8°C. For long term storage, aliquot in working volumes without diluting and store at -20°C in a manual defrost freezer. Avoid Repeated Freeze Thaw Cycles. Applications and Recommended Usage? Quality Tested by Leinco CODEX® This CD5 (Clone UCHT-2) antibody is formulated to simplify the antibody preparation needed when performing a CODEX® barcode conjugate. The suggested concentration is 0.5 mg/ml. RRID AB_2893566 Country of Origin USA Each investigator should determine their own optimal working dilution for specific applications. See directions on lot specific datasheets, as information may periodically change. DescriptionSpecificity Mouse Anti-Human CD5 (Clone UCHT-2) recognizes Human CD5. This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype. Anti-Human CD5 recognizes a human T-lymphocyte surface membrane antigen (Mr 67 kDa). Antigen Distribution The CD5 antigen is present on approximately 70% of normal peripheral blood lymphocytes and >90% of all T-lymphocytes. T-lymphocytes in the thymus stain weakly while peripheral T-cells stain strongly. Monocytes, granulocytes and NK cells are not stained.1 Anti-CD5 also reacts with a distinct subset of normal B-lymphocytes, occasional cells in B-lymphocyte areas of spleen and lymph node, and most Ig+ B-chronic lymphoblastic leukemia (CLL) cells. The CD5 antigen has also been shown to be present on some lymphomas. Background Anti-Human CD5 can be used in research to study B-lymphocyte subsets or characterization of leukemias and lymphomas. Antigen DetailsProtein Ligand/Receptor CD72 PubMed NCBI Gene Bank ID References & Citations1. Leukocyte Typing VI (1995) Oxford University Press
2. Leukocyte Typing III (1987) Oxford University Press
3. Beverly, P. C. L. et al. (1981) "Protides of the Biological Fluids," Vol. XXIX, Peeters, H. (ed.), Pergamon Press, Oxford, 653 Technical Protocols |
Related Products
Formats Available
- -
- -
Prod No. | Description |
---|---|
C2059 | |
C113 | |
C114 | |
C115 | |
C2051 | |
C2052 | |
C2053 | |
C2055 | |
C2057 | |
C505 | |
C116 | |
C1025 | |
C311 |
Products are for research use only. Not for use in diagnostic or therapeutic procedures.